Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease.
Ferguson
J J
JJ
Texas Heart Institute, Houston, USA.
Gonzalez
E R
ER
Kannel
W B
WB
Olin
J W
JW
Raps
E C
EC
D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D002545:Brain Ischemia / Q000150:complications / Q000517:prevention & control*; D000077144:Clopidogrel; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014652:Vascular Diseases / Q000150:complications / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin